Paper |
Title |
Page |
THCDMH01 |
Magnetic Field of the 40-80 MeV H− Cyclotron C-80: Experiments and Calculations |
103 |
|
- S.A. Artamonov, E.M. Ivanov, G.A. Riabov
PNPI, Gatchina, Leningrad District, Russia
|
|
|
The paper concerns to the final parameters of the magnetic field distribution of the new H-minus isochronous cyclotron C-80 and results of 3D computer calculations and experimental measurements before the installation of the vacuum chamber into the cyclotron gap. The cyclotron C-80 with variably energy 40 - 80 MeV and current up to 100 mkA is planned to be used as for applied physics program - for production of medicine isotopes, for therapy of eye melanoma and surface forms of cancer, for radiation resistance tests of electronic components - as well as for fundamental research in nuclear physics, solid state physics and biology.
|
|
|
Slides THCDMH01 [6.524 MB]
|
|
DOI • |
reference for this paper
※ https://doi.org/10.18429/JACoW-RUPAC2018-THCDMH01
|
|
Export • |
reference for this paper using
※ BibTeX,
※ LaTeX,
※ Text/Word,
※ RIS,
※ EndNote (xml)
|
|
|
FRCAMH03 |
Radiation Oncology Ophthalmic Center Based on the C-80 Accelerator at the NRC "Kurchatov Institute" - PNPI |
145 |
|
- A.N. Chernykh, E.M. Ivanov
PNPI, Gatchina, Leningrad District, Russia
- V.S. Khoroshkov
ITEP, Moscow, Russia
- G.I. Klenov
MRTI RAS, Moscow, Russia
|
|
|
Radiotherapy along with surgery and chemotherapy is a common method treatment for cancer. In developed countries, radiotherapy is used in 70% of cases of treatment, both individually and together. In recent years, proton radiation therapy intensively implement at clinical practice. It is proved that proton therapy is an extremely effective treatment method in the field of cancer eye in which the five-year survival is up to 98%. However, long-term observations show that the possibility of late radiation reactions that lead to atrophic and degenerative changes and the need to remove the eye. These complications are strongly manifested after irradiation of tumors sprouted more than 10 mm into the eye. The reasons that lead to such unpleasant consequences of exposure may be related to positioning errors. Based on years of experience of radiation oncology ophthalmic patients, beam installation, allowing to increase the pointing accuracy of the proton beam on the irradiated target was design. The proposed innovation is supposed to allow improving the quality of radiation. As result of studies PNPI and ITEP have joined forces to create on the basis of the cyclotron C-80, functioning in the PNPI from 2017, radiation oncology ophthalmic center of proton beam therapy that can provide the need for this type of medical care for the whole North-West region of Russia. The report describes the composition and innovative solutions of the Center's equipment.
|
|
|
Slides FRCAMH03 [9.442 MB]
|
|
DOI • |
reference for this paper
※ https://doi.org/10.18429/JACoW-RUPAC2018-FRCAMH03
|
|
Export • |
reference for this paper using
※ BibTeX,
※ LaTeX,
※ Text/Word,
※ RIS,
※ EndNote (xml)
|
|
|